Sign in

CIK 0001023024 · Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
582301143
Phone
6097591810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Planned sale SVP & CFO sold 2,850 shares at $72.87 ($207,680)
  2. 4 Planned sale PRESIDENT & CEO sold 5,400 shares at $71.89 ($388,206)
  3. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $73.59 ($36,795)
  4. 4 Planned sale SVP & CFO sold 2,850 shares at $73.00 ($208,050)
  5. 4 Planned sale PRESIDENT & CEO sold 5,400 shares at $71.00 ($383,400)
  6. 4 Planned sale Director sold 1,000 shares at $71.53 ($71,530)
  7. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $70.79 ($35,395)
  8. 4 Planned sale SVP & CFO sold 2,850 shares at $72.80 ($207,480)
  9. 4 Grant or award Director acquired 6,662 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Planned sale PRESIDENT & CEO sold 5,400 shares at $74.30 ($401,220)
  12. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $75.48 ($37,740)
  13. 4 Open-market sale SVP, GENERICS sold 3,162 shares at $77.00 ($243,474)
  14. 4 Planned sale SVP & CFO sold 2,850 shares at $81.36 ($231,876)
  15. 4 Shares withheld for taxes SR. VP, GENERAL COUNSEL & SEC. gave up 2,466 shares (to pay taxes)
  16. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $81.84 ($40,920)
  17. 4 Planned sale SVP & CFO sold 3,313 shares at $86.00 ($284,918)
  18. 4 Planned sale SVP & CFO sold 2,850 shares at $84.12 ($239,742)
  19. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $82.03 ($41,015)
  20. 4 Grant or award Director acquired 4,357 shares (grant or award)

Page 1 of 42 · 833 filings